ZenaTech Letter to Shareholders Outlines 316% Q2 Revenue Growth and Seventh Consecutive Quarter of Sequential Growth
October 1, 2026
CEO Manny Krakaris unveils the benefits of Augmedix, battling a shortage of healthcare staff, an aging population, and outdated traditions surrounding normalized medical practices.